Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection

Cellular Microbiology

Volumn 14, Issue 4, 2012, Pages 485-499

  Haneda, Takeshi ^a   Ishii, Yuta ^a   Shimizu, Hiromichi ^a   Ohshima, Keiko ^a   Iida, Naoyuki ^a   Danbara, Hirofumi ^a   Okada, Nobuhiko ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; LYASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTHREONINE LYASE SPVC; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOPLASM; ENTEROCOLITIS; HOST CELL; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SALMONELLA ENTERICA; SALMONELLA ENTEROCOLITIS;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CARBON-OXYGEN LYASES; CYTOSOL; ENTEROCOLITIS; FEMALE; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTESTINES; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; NF-KAPPA B; PHOSPHORYLATION; PLASMIDS; PROTEIN TRANSPORT; RNA, MESSENGER; SALMONELLA; SALMONELLA INFECTIONS; SPLEEN; STREPTOMYCIN;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84858284611     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01733.x     Document Type: Article

References (58)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Alfano, J.R., and Collmer, A. (2004) Type III secretion system effector proteins: double agents in bacterial disease and plant defense. Annu Rev Phytopathol 42: 385-414.
3. Arbibe, L., Kim, D.W., Batsche, E., Pedron, T., Mateescu, B., Muchardt, C., etal. (2007) An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8: 47-56.
4. Ashida, H., Kim, M., Schmidt-Supprian, M., Ma, A., Ogawa, M., and Sasakawa, C. (2010) A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol 12: 66-73, sup pp. 61-69.
5. Ausubel, F.M. (2005) Are innate immune signaling pathways in plants and animals conserved? Nat Immunol 6: 973-979.
6. Bajaj, V., Hwang, C., and Lee, C.A. (1995) hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol Microbiol 18: 715-727.
7. Barthel, M., Hapfelmeier, S., Quintanilla-Martinez, L., Kremer, M., Rohde, M., Hogardt, M., etal. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
8. Brown, N.F., Vallance, B.A., Coombes, B.K., Valdez, Y., Coburn, B.A., and Finlay, B.B. (2005) Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS Pathog 1: e32.
9. Bruno, V.M., Hannemann, S., Lara-Tejero, M., Flavell, R.A., Kleinstein, S.H., and Galán, J.E. (2009) Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog 5: e1000538.
10. Bustamante, V.H., Martinez, L.C., Santana, F.J., Knodler, L.A., Steele-Mortimer, O., and Puente, J.L. (2008) HilD-mediated transcriptional cross-talk between SPI-1 and SPI-2. Proc Natl Acad Sci USA 105: 14591-14596.
11. Coombes, B.K., Coburn, B.A., Potter, A.A., Gomis, S., Mirakhur, K., Li, Y., and Finlay, B.B. (2005) Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun 73: 7161-7169.
12. Datsenko, K.A., and Wanner, B.L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
13. Drecktrah, D., Knodler, L.A., Galbraith, K., and Steele-Mortimer, O. (2005) The Salmonella SPI1 effector SopB stimulates nitric oxide production long after invasion. Cell Microbiol 7: 105-113.
14. Du, F., and Galán, J.E. (2009) Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog 5: e1000595.
15. Fu, Y., and Galán, J.E. (1999) A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401: 293-297.
16. Galán, J.E., and Wolf-Watz, H. (2006) Protein delivery into eukaryotic cells by type III secretion machines. Nature 444: 567-573.
17. Galán, J.E., Ginocchio, C., and Costeas, P. (1992) Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J Bacteriol 174: 4338-4349.
18. Godinez, I., Haneda, T., Raffatellu, M., George, M.D., Paixão, T.A., Rolan, H.G., etal. (2008) T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa. Infect Immun 76: 2008-2017.
19. Gotoh, H., Okada, N., Kim, Y.G., Shiraishi, K., Hirami, N., Haneda, T., etal. (2003) Extracellular secretion of the virulence plasmid-encoded ADP-ribosyltransferase SpvB in Salmonella. Microb Pathog 34: 227-238.
20. Grant, S.R., Fisher, E.J., Chang, J.H., Mole, B.M., and Dangl, J.L. (2006) Subterfuge and manipulation: type III effector proteins of phytopathogenic bacteria. Annu Rev Microbiol 60: 425-449.
21. Haneda, T., Winter, S.E., Butler, B.P., Wilson, R.P., Tukel, C., Winter, M.G., etal. (2009) The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism. Infect Immun 77: 2932-2942.
22. Hapfelmeier, S., and Hardt, W.D. (2005) A mouse model for S.typhimurium-induced enterocolitis. Trends Microbiol 13: 497-503.
23. Hapfelmeier, S., Müller, A.J., Stecher, B., Kaiser, P., Barthel, M., Endt, K., etal. (2008) Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S.Typhimurium colitis. J Exp Med 205: 437-450.
24. Haraga, A., and Miller, S.I. (2003) A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun 71: 4052-4058.
25. Haraga, A., and Miller, S.I. (2006) A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol 8: 837-846.
26. He, P., Shan, L., Lin, N.C., Martin, G.B., Kemmerling, B., Nurnberger, T., and Sheen, J. (2006) Specific bacterial suppressors of MAMP signaling upstream of MAPKKK in Arabidopsis innate immunity. Cell 125: 563-575.
27. He, S.Y., Nomura, K., and Whittam, T.S. (2004) Type III protein secretion mechanism in mammalian and plant pathogens. Biochim Biophys Acta 1694: 181-206.
28. Jones, R.M., Wu, H., Wentworth, C., Luo, L., Collier-Hyams, L., and Neish, A.S. (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3: 233-244.
29. Kappeli, R., Kaiser, P., Stecher, B., and Hardt, W.D. (2011) Roles of spvB and spvC in S.Typhimurium colitis via the alternative pathway. Int J Med Microbiol 301: 117-124.
30. Kim, D.W., Lenzen, G., Page, A.L., Legrain, P., Sansonetti, P.J., and Parsot, C. (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102: 14046-14051.
31. Kosako, H., Yamaguchi, N., Aranami, C., Ushiyama, M., Kose, S., Imamoto, N., etal. (2009) Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat Struct Mol Biol 16: 1026-1035.
32. Kramer, R.W., Slagowski, N.L., Eze, N.A., Giddings, K.S., Morrison, M.F., Siggers, K.A., etal. (2007) Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog 3: e21.
33. Li, H., Xu, H., Zhou, Y., Zhang, J., Long, C., Li, S., etal. (2007) The phosphothreonine lyase activity of a bacterial type III effector family. Science 315: 1000-1003.
34. Matsui, H., Bacot, C.M., Garlington, W.A., Doyle, T.J., Roberts, S., and Gulig, P.A. (2001) Virulence plasmid-borne spvB and spvC genes can replace the 90-kilobase plasmid in conferring virulence to Salmonella enterica serovar Typhimurium in subcutaneously inoculated mice. J Bacteriol 183: 4652-4658.
35. Mazurkiewicz, P., Thomas, J., Thompson, J.A., Liu, M., Arbibe, L., Sansonetti, P., and Holden, D.W. (2008) SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol Microbiol 67: 1371-1383.
36. Metcalf, W.W., Jiang, W., Daniels, L.L., Kim, S.K., Haldimann, A., and Wanner, B.L. (1996) Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria. Plasmid 35: 1-13.
37. Miki, T., Shibagaki, Y., Danbara, H., and Okada, N. (2009) Functional characterization of SsaE, a novel chaperone protein of the type III secretion system encoded by Salmonella pathogenicity island 2. J Bacteriol 191: 6843-6854.
38. Miki, T., Iguchi, M., Akiba, K., Hosono, M., Sobue, T., Danbara, H., and Okada, N. (2010) Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes. Mol Microbiol 77: 855-872.
39. Mittal, R., Peak-Chew, S.Y., and McMahon, H.T. (2006) Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103: 18574-18579.
40. Mudgett, M.B. (2005) New insights to the function of phytopathogenic bacterial type III effectors in plants. Annu Rev Plant Biol 56: 509-531.
41. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H.L., Goldsmith, E.J., and Orth, K. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
42. Müller, A.J., Hoffmann, C., Galle, M., Van Den Broeke, A., Heikenwalder, M., Falter, L., etal. (2009) The S.Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6: 125-136.
43. Murli, S., Watson, R.O., and Galán, J.E. (2001) Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell Microbiol 3: 795-810.
44. Navarro, L., Alto, N.M., and Dixon, J.E. (2005) Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol 8: 21-27.
45. Pickard, D., Wain, J., Baker, S., Line, A., Chohan, S., Fookes, M., etal. (2003) Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol 185: 5055-5065.
46. Pritchard, C.A., Samuels, M.L., Bosch, E., and McMahon, M. (1995) Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 15: 6430-6442.
47. Raffatellu, M., Santos, R.L., Chessa, D., Wilson, R.P., Winter, S.E., Rossetti, C.A., etal. (2007) The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun 75: 4342-4350.
48. Ribet, D., and Cossart, P. (2010) Pathogen-mediated posttranslational modifications: a re-emerging field. Cell 143: 694-702.
49. Rohde, J.R., Breitkreutz, A., Chenal, A., Sansonetti, P.J., and Parsot, C. (2007) Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1: 77-83.
50. Sory, M.P., and Cornelis, G.R. (1994) Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol 14: 583-594.
51. Stecher, B., Robbiani, R., Walker, A.W., Westendorf, A.M., Barthel, M., Kremer, M., etal. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5: 2177-2189.
52. Tsolis, R.M., Young, G.M., Solnick, J.V., and Bäumler, A.J. (2008) From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol 6: 883-892.
53. Valdez, Y., Grassl, G.A., Guttman, J.A., Coburn, B., Gros, P., Vallance, B.A., and Finlay, B.B. (2009) Nramp1 drives an accelerated inflammatory response during Salmonella-induced colitis in mice. Cell Microbiol 11: 351-362.
54. Wilson, R.P., Raffatellu, M., Chessa, D., Winter, S.E., Tukel, C., and Bäumler, A.J. (2008) The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 10: 876-890.
55. Wu, H., Jones, R.M., and Neish, A.S. (2011) The Salmonella effector AvrA mediates bacterial intracellular survival during infection in vivo. Cell Microbiol 14: 28-39.
56. Yen, H., Ooka, T., Iguchi, A., Hayashi, T., Sugimoto, N., and Tobe, T. (2010) NleC, a type III secretion protease, compromises NF-kappaB activation by targeting p65/RelA. PLoS Pathog 6: e1001231.
57. Zhang, Y., Deng, Q., Porath, J.A., Williams, C.L., Pederson-Gulrud, K.J., and Barbieri, J.T. (2007) Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS. Cell Microbiol 9: 2192-2201.
58. Zhu, Y., Li, H., Long, C., Hu, L., Xu, H., Liu, L., etal. (2007) Structural insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Mol Cell 28: 899-913.